Cannon Gillian Insider Trades

Insider Trading History

Track insider trading activity for Cannon Gillian. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Corcept Therapeutics
Corcept Therapeutics CORT
Director
Holding Value $0 0 shares
Last Trade
Sep 10, 2025 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$529k 7,393 shares
$71.62
$74.89
Corcept Therapeutics
Corcept Therapeutics CORT
Director
Holding Value $3.67M 49,000 shares
Last Trade
Sep 04, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$763k 11,000 shares
$69.37
$74.89
Corcept Therapeutics
Corcept Therapeutics CORT
Director
Holding Value $824k 11,000 shares
Last Trade
Sep 04, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$763k 11,000 shares
$69.37
$74.89
Corcept Therapeutics
Corcept Therapeutics CORT
Director
Holding Value $554k 7,393 shares
Last Trade
Sep 04, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$253k 3,607 shares
$70.13
$74.89
Corcept Therapeutics
Corcept Therapeutics CORT
Director
Holding Value $1.12M 15,000 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.08M 15,000 shares
$72.27
$74.89
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $901k 17,012 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$523k 17,012 shares
$30.73
$52.99
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $824k 15,542 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$593k 15,542 shares
$38.16
$52.99
Corcept Therapeutics
Corcept Therapeutics CORT
Director
Holding Value $2.25M 30,000 shares
Last Trade
May 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$843k 30,000 shares
$28.09
$74.89
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $1.48M 28,000 shares
Last Trade
Aug 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.07M 28,000 shares
$38.39
$52.99
Corcept Therapeutics
Corcept Therapeutics CORT
Director
Holding Value $2.25M 30,000 shares
Last Trade
May 19, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$723k 30,000 shares
$24.10
$74.89
Corcept Therapeutics
Corcept Therapeutics CORT
Director
Holding Value $1.5M 20,000 shares
Last Trade
May 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$834k 40,000 shares
$20.84
$74.89
Corcept Therapeutics
Corcept Therapeutics CORT
Director
Holding Value $1.5M 20,000 shares
Last Trade
May 26, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$429k 20,000 shares
$21.45
$74.89
Corcept Therapeutics
Corcept Therapeutics CORT
Director
Holding Value $4.49M 60,000 shares
Last Trade
Dec 01, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.38M 60,000 shares
$22.99
$74.89

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up